Related references
Note: Only part of the references are listed.Herb-drug interaction studies of herbs used in treatment of cardiovascular disorders-A narrative review of preclinical and clinical studies
Aaftab S. Shaikh et al.
PHYTOTHERAPY RESEARCH (2020)
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Kamran Mansouri et al.
BMC CANCER (2020)
Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment
S. Parylo et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4
Mei-Hui Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans
Wijdan M. Dabeek et al.
NUTRIENTS (2019)
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors
Stefano Fogli et al.
CANCER TREATMENT REVIEWS (2019)
Herbal Interaction With Chemotherapeutic Drugs-A Focus on Clinically Significant Findings
Pius S. Fasinu et al.
FRONTIERS IN ONCOLOGY (2019)
Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre
Megane Jermini et al.
SCIENTIFIC REPORTS (2019)
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Anand Shah et al.
CLINICAL CANCER RESEARCH (2018)
Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy
Caroline Gay et al.
HEMATOLOGICAL ONCOLOGY (2017)
Physiologically Based Pharmacokinetic Modeling of Palbociclib
Yanke Yu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
Jeffry Adiwidjaja et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Pharmacokinetic interactions of curcuminoids with conventional drugs: A review
Roodabeh Bahramsoltani et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
Laura M. Spring et al.
ONCOLOGIST (2017)
Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance
Allan Ramos-Esquivel et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account
Roberto Collado-Borrell et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Interactions between CYP3A4 and Dietary Polyphenols
Loai Basheer et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data
Sumit Arora et al.
TOXICOLOGY LETTERS (2015)
Evaluation of Inhibitory Effects of Caffeic acid and Quercetin on Human Liver Cytochrome P450 Activities
Himanshu Rastogi et al.
PHYTOTHERAPY RESEARCH (2014)
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Subash C. Gupta et al.
AAPS JOURNAL (2013)
Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients
Andrew K. L. Goey et al.
CANCER TREATMENT REVIEWS (2013)
Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models
Venkatesh R. Challa et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2013)
Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models
P. Ravindra Babu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2013)
Effects of Quercetin on the Bioavailability of Doxorubicin in Rats: Role of CYP3A4 and P-gp Inhibition by Quercetin
Jun-Shik Choi et al.
ARCHIVES OF PHARMACAL RESEARCH (2011)
Quercetin and Rutin Reduced the Bioavailability of Cyclosporine from Neoral, an Immunosuppressant, through Activating P-Glycoprotein and CYP 3A4
Chung-Ping Yu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin
Yi-Dong Yan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Chemistry and Biochemistry of Dietary Polyphenols
Rong Tsao
NUTRIENTS (2010)
Quercetin pretreatment increases the bioavailability of pioglitazone in rats: Involvement of CYP3A inhibition
Sudhir N. Umathe et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans
Sarah Egert et al.
JOURNAL OF NUTRITION (2008)
Dietary polyphenols and their biological significance
Xiuzhen Han et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2007)
Structural basis for ligand promiscuity in cytochrome P450 3A4
Marika Ekroos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats
SC Shin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse
SP Valentine et al.
LIFE SCIENCES (2006)
Herb-drug interactions: an overview of the clinical evidence
AA Izzo
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Effect of St John's wort on imatinib mesylate pharmacokinetics
RF Frye et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The current position of complementary/alternative medicine in cancer
E Ernst
EUROPEAN JOURNAL OF CANCER (2003)
Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions
R Yuan et al.
DRUG METABOLISM AND DISPOSITION (2002)
Share Paper
